Almac Group Opens Registration for Internationally Recognised Process Chemistry Forum in Belfast
Registration is now open for the Nordic-Irish Process Chemistry Conference, June 2023
Almac Sciences, a member of the Almac Group, is delighted to announce that registration is now open for the Nordic-Irish Process Chemistry Forum, taking place from 6 - 8 June 2023. This internationally recognised forum for leaders in process chemistry, will be held in Belfast, Northern Ireland for the very first time in the event’s history.
As a leader in process chemistry and R&D, Almac Sciences will host the forum, which has a long history of attracting some of the most respected and innovative speakers in the world of chemistry. The Belfast event will be the 9th forum since it was founded in 2004.
The main driver of the forum has always been to bring together scientists who are involved in the design and scale up of chemical processes. This upcoming event in Belfast is no exception — an impressive line-up of industrial and academic speakers has been secured for the forum including Professor Oliver Kappe, Professor Anthony Burke and Professor Andreas Liese, covering a range of subjects within the process chemistry field.
Professor Tom Moody, VP Technology Development & Commercialisation at Almac & Arran Chemical Company commented: “We are excited to share our agenda and formally open this event for registration. Participants will truly benefit from learning about the rich chemistry expertise and innovative research taking place among industry and academia across the EU and within the island of Ireland. For the first time we are also giving PhD students the opportunity to showcase their research studies in front of industry peers. There will be no better audience to engage with and I strongly urge early registration.”
The Nordic Irish Process Chemistry Forum will be held from 6 - 8 June 2023 at W5, Belfast, Northern Ireland. Visit the dedicated webpage at https://npcf2023.com to register and find out more about the agenda and participation opportunities.
About Almac Group
A unique culture delivering exceptional solutions
The Almac Group is an established contract development and manufacturing organisation providing an extensive range of integrated services across the drug development lifecycle to the pharmaceutical and biotech sectors globally.
Our innovative services range from R&D, biomarker discovery development and commercialisation, API manufacture, formulation development, clinical trial supply, IRT (IVRS/IWRS) through to commercial-scale manufacture.
The international company is a privately owned organisation that has grown organically over the past five decades now employing over 5,000 highly skilled personnel across 17 facilities including Europe, the US and Asia.
We have a global reputation for excellence built over 50 years of client service, delivering expertise right across the drug development lifecycle and offering a tailored solution to each of our clients.
To keep up to date with our latest news, follow us on Twitter and LinkedIn or visit almacgroup.com.
